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Abstract The Wiskott-Aldrich syndrome (WAS) is a rare
immunodeficiency disease affecting mainly platelets and lym-
phocytes. Here, we show that the WAS gene product, WASp, is
tyrosine phosphorylated upon aggregation of the high affinity
IgE receptor (FcORI) at the surface of RBL-2H3 rat tumor mast
cells. Lyn and the Bruton’s tyrosine kinase (Btk), two protein
tyrosine kinases involved in FcORI-signaling phosphorylate
WASp and interact with WASp in vivo. Interestingly, expression
of a GTPase defective mutant form of CDC42, that interacts
with WASp, is accompanied by a substantial increase in WASp
tyrosine phosphorylation. This study suggests that activated
CDC42 recruits WASp to the plasma membrane where it
becomes phosphorylated by Lyn and Btk. We conclude that
WASp represents a connection between protein tyrosine kinase
signaling pathways and CDC42 function in cytoskeleton and cell
growth regulation in hematopoietic cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The Wiskott-Aldrich Syndrome (WAS) is a severe disease
that results in thrombocytopenia and abnormally sized plate-
lets as well as susceptibily to recurrent infections and eczema
[1]. The WAS gene has been recently cloned [2] and its prod-
uct, WASp, interacts with the GTP-bound form of CDC42, a
member of the Rho GTPase family [3^5]. Rho GTPases reg-
ulate actin cytoskeleton reorganization, G1 cell cycle progres-
sion and transcriptional regulation in response to several stim-
uli (for review see [6]) and WASp serves as an e¡ector for
CDC42 function in actin remodeling [4,7]. In vitro studies
have described interactions between WASp and various pro-
tein tyrosine kinases (PTKs) [8^10]. Although tyrosine phos-
phorylation of WASp has not been reported yet, these di¡er-
ent interactions point at an important function for WASp in
hematopoietic cell signaling.
In mast cells, aggregation of FcORI, the high a⁄nity recep-
tor for IgE, triggers various responses including release of
in£ammatory mediators of allergy and a dramatic reorganiza-
tion of the actin cytoskeleton [11]. We have recently estab-
lished that in RBL-2H3 rat tumor mast cells, two Rho
GTPases, Rac1 and CDC42, control speci¢c pathways leading
to actin remodeling and serotonin release in response to
FcORI engagement [12]. As in other systems such as induction
of stress ¢bers by lysophosphatidic acid [13], FcORI-induced
actin reorganization depends on tyrosine phosphorylation
events and is blocked by tyrosine kinase inhibitors [14,15].
At least three classes of non-receptor tyrosine kinases are
sequentially engaged during FcORI activation: the Src-family
kinases Src, yes and lyn [16]; Syk, a member of the Syk/
Zap70-family kinases [17,18]; and ¢nally, members of the
Tec-family kinases such as Btk [19] which is defective in hu-
man X-linked agammaglobulinemia (XLA) [20] and murine
X-linked immunode¢ciency (Xid) [21].
An important question remains as to how PTK engagement
couples to Rho GTPase activation and then to actin remodel-
ing. On the one hand, PTKs may regulate the activity of
guanine nucleotide exchange factors (GEF), i.e. the proteins
that promote GDP/GTP exchange on Rho GTPases and
thereby stimulate their transition to an active conformation.
This hypothesis is supported by the ¢nding that p95Vav,
which becomes rapidly tyrosine phosphorylated upon
FcORI-crosslinking [22], is a Rac1-speci¢c GEF whose activity
is controlled by tyrosine phosphorylation [23]. p95Vav may
therefore link early phosphorylation events to Rho GTPase
(Rac1) activation. On the other hand, PTKs may also regulate
the function/activity of Rho GTPase downstream e¡ectors
including the product of the WAS gene which interacts with
isolated SH3 domains from Src- and Tec-family PTKs in vitro
[8^10].
We have investigated the participation of WASp in FcORI
signaling. We demonstrate that WASp is constitutively tyro-
sine phosphorylated in RBL-2H3 cells and that phosphoryla-
tion is increased in response to FcORI-aggregation. Overex-
pression of Lyn or Btk is su⁄cient to induce the
phosphorylation of WASp and both PTKs are found com-
plexed to WASp in RBL-2H3 cells. Finally, tyrosine phos-
phorylation of WASp by Lyn or Btk is enhanced upon coex-
pression of a GTPase-defective mutant form of CDC42,
suggesting that interaction with activated CDC42 at the mem-
brane facilitates tyrosine phosphorylation of WASp.
2. Materials and methods
2.1. Antibodies and reagents
Rat anti-DNP IgE (clone LO-DNP30) was obtained from LO-
IMEX (Brussels, Belgium). Anti-rat FcORIK chain (clone BC4) was
kindly provided by Dr. R.P. Siraganian (NIH, Bethesda, MD, USA).
The monoclonal anti-phosphotyrosine antibody 4G10 was purchased
from Upstate Biotechnology. Anti-p53/p56 Lyn rabbit polyclonal
antibodies were from Santa Cruz Biotechnology. FITC-con¢gurated
anti-CD16 mAb was obtained from Coulter-Immunotech (Marseille,
France). The anti-BTK antibody is a rabbit a⁄nity puri¢ed antiserum
raised against amino acid residues 71^93 [24]. Anti-WASp rabbit anti-
bodies were raised against amino acid residues 201^321 of human
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WASp expressed as a fusion protein with GST after cleavage with
thrombin and removal of the GST moiety. Horseradish peroxidase
(HRP) conjugated goat anti-mouse and HRP conjugated protein A
were purchased from Sigma. Unless indicated, chemicals were pur-
chased from Sigma.
2.2. Expression constructs
The myc tag was inserted at the C-terminal end of WASp as fol-
lows. A 180-bp PCR fragment corresponding to the carboxy terminus
of WASp was generated between a 5P primer (5P-CAGGGAATT-
CAGCTGAAC-3P) spanning an internal EcoRI site in the WAS
cDNA (underlined) and a 3P primer (5P-CTACTACTTACCCTACT-
GCTTGTTTTTGAGTAGAGCTTCTCCTAGACACTTTCGAATT-
CAACTA-3P) coding for the myc epitope (double underlined) and
including a stop codon and a HindIII restriction site (underlined).
This fragment was subcloned into pGEM1 (Promega, Madison, WI,
USA), sequenced and ¢nally inserted in place of the wild-type se-
quence in the WAS cDNA cloned into pGEM1. The pGEM1-
V12CDC42VHs construct has been already described [25].
2.3. Cell culture, vaccinia infection and transfection
Rat basophil leukemia (RBL-2H3) cells and baby hamster kidney
(BHK-21) cells were maintained as described [12,26]. Transient ex-
pression studies were carried out using the vaccinia recombinant T7
RNA polymerase virus system (VT7, [27]). Cells seeded at a density of
1.5U106 cells/9-cm2 well were infected the following day with VT7 at
3^5 pfu/cell. Coexpression of PTKs was obtained by coinfection with
recombinant vaccinia viruses expressing the PTKs Btk, Btk*,
BtkvSH3, Lyn (a gift from D.J. Rawlings, UCLA, CA, USA) or
with a vaccinia virus expressing a CD16/7/Syk chimera [28]. After
45 min infection at 37‡C, cells were transfected with pGEM1 con-
structs using the Lipofectamine Reagent (Gibco-BRL) as previously
described [12]. Cells were cultured for 6 h in DMEM supplemented
with 10 mM HEPES, pH 7.2, and then lysed in ice cold bu¡er (1%
NP-40, 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 100 mM sodium
orthovanadate, 1 mM EDTA and protease inhibitors). After 20 min
at 4‡C lysates were centrifuged at 4‡C for 20 min at 15 000 rpm.
Stable WASp-myc transfected cell lines were generated by electropo-
ration of the WASp-myc encoding sequence inserted into pNT-Neo as
described [12].
2.4. GST fusion constructs, a⁄nity puri¢cation and immunoblotting
analysis
The GST-SH3 Btk construct (amino acid positions 217^277 of hu-
man Btk) and the GST-SH3 Btk construct with a proline-265 to
leucine substitution have been described [24]. The GST-ProSH3 Btk
construct was generated by PCR ampli¢cation of a cDNA fragment
corresponding to amino acids 185^277 of human BTK using the fol-
lowing primers: 5P-GAGGGATCCACTAGTGAGCTGAAAAAGG-
TTGTGG-3P and 5P-TAACCCGGGGATTCAATTGAGTCTTCTG-
CTTCAGGACAT-3P). The PCR product was subcloned into the
pGEX-2T expression vector (Pharmacia Biotech) and selected clones
were con¢rmed by sequencing. Production of GST fusion proteins
was performed as described by the manufacturer (Pharmacia Biotech).
Immunoprecipitation or a⁄nity puri¢cation with GST fusion pro-
teins were performed at 4‡C for 2 h in the presence of either speci¢c
antibodies bound to protein A-Sepharose (Pharmacia Biotech) or
GST constructs bound to glutathione-Sepharose (Pharmacia Biotech).
Puri¢ed proteins were extensively washed in lysis bu¡er, subjected to
SDS-PAGE, and transferred to Immobilon-P membranes (Millipore).
Membranes were blocked with 5% non-fat milk or 0.5% BSA in PBS/
0.05% Tween 20, followed by incubation with the indicated antibod-
ies. Bound antibodies were revealed with HRP-conjugated secondary
antibodies or HRP-protein A and visualized by chemiluminescence
with the ECL system (Amersham).
3. Results
3.1. FcORI aggregation induces tyrosine phosphorylation
of WASp
In order to purify WASp from cell lysates we made use of
the observation that the isolated SH3 domain of Btk interacts
with WASp in vitro [9,10]. Lysates of unstimulated RBL-2H3
cells were incubated with GST fusion proteins comprising the
Btk SH3 domain alone (GST-SH3) or extended N-terminally
to a proline-rich region of Btk (GST-proSH3). We chose this
strategy because the rabbit polyclonal antibodies we have
raised against WASp were ine⁄cient for immunoprecipitation
analysis. After extensive washing, immunoblotting analysis of
bound proteins with anti-WASp antibodies showed that both
GST recombinant proteins interacted with WASp (Fig. 1A,
lanes 1 and 3). As we previously described [24], the introduc-
tion of a point mutation in the Btk SH3 domain (Pro265 to
Leu) prevented this interaction (Fig. 1A, lanes 2 and 4). Since
binding appeared more speci¢c with the proline-rich contain-
ing fusion protein ([24] and data not shown), the proSH3
construct was used throughout for the subsequent experi-
ments.
As shown in Fig. 1B immunoblotting analysis with anti-
phosphotyrosine mAb (4G10 blot, upper panel) revealed
that following crosslinking of FcORI, three phosphotyrosine
containing proteins migrating with an apparent molecular
weight of V65, V75 and V125 kDa could be puri¢ed
from RBL-2H3 cell lysate using the Btk GST-proSH3 con-
struct (lane 3). We identi¢ed the 125-kDa molecular weight
species (asterisk) as Cbl (data not shown). The identity of the
V75-kDa (arrow) protein is presently unknown. Analysis of
unstimulated cell lysate detected only a very low amount of
tyrosine phosphorylated 65- and 125-kDa proteins (Fig. 1B,
lane 1). The blot was stripped and reprobed with Anti-WASp
that revealed a protein comigrating with the 65-kDa phospho-
tyrosine containing species (lanes 1 and 3, middle panel). The
identity of the 65-kDa protein was further con¢rmed by tran-
siently expressing C-terminally myc-tagged WASp. Trans-
fected RBL-2H3 cells were lysed prior or 5 min after FcORI
crosslinking and lysates were incubated with the GST-proSH3
construct. Immunoblotting analysis with anti-phosphotyrosine
mAb revealed an additional polypeptide that migrated slightly
slower than endogenous WASp (upper panel, lanes 2 and 4)
and which was detected by both anti-WASp and anti-myc tag
antibodies (middle and lower panels, respectively). As a ¢nal
proof of the identity of the 65-kDa phosphotyrosine protein
as WASp, stably transfected RBL cells expressing WASp-myc
were lyzed without or after pervanadate treatment and
WASp-myc was immunoprecipitated with anti-myc tag
mAb. Anti-phosphotyrosine immunoblotting analysis detected
the presence of tyrosine phosphorylated WASp-myc in the
anti-myc immunoprecipitate from stimulated cells (Fig. 1C,
lane 4).
Altogether, these results demonstrate that the 65-kDa
WASp protein exhibits constitutive tyrosine phosphorylation
that is strongly increased upon FcORI stimulation in RBL-
2H3 cells.
3.1.1. Overexpression of Lyn induces tyrosine phosphoryla-
tion of WASp. In an attempt to identify the PTK(s) respon-
sible for WASp phosphorylation, we overexpressed Lyn, Btk
and Syk that are involved in FcORI signaling [29]. Expression
of the PTKs was achieved upon infection of RBL-2H3 cells
with recombinant vaccinia viruses (see Fig. 2B). Anti-phos-
photyrosine immunoblot of total cell lysates showed that
overexpressed Syk and Lyn induced the tyrosine phosphory-
lation of a number of cellular proteins (Fig. 2A, lanes 1^2 and
5^6), while Btk or an activated PH domain mutant form of
Btk, Btk*, [30] were inactive (lanes 3^4 and data not shown).
Anti-phosphotyrosine immunoblot analysis of the proteins
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bound to the Btk GST-proSH3 construct showed that over-
expression of Lyn was su⁄cient to induce phosphorylation of
both endogenous and myc-tagged WASp (Fig. 2C, lanes 5 and
6). In contrast, overexpression of Syk did not result in any
detectable phosphorylation of WASp (lanes 1^4). In agree-
ment with the absence of overall phosphorylation in total
cell lysates, WASp was not phosphorylated in Btk overex-
pressing RBL-2H3 cells (lanes 3 and 4).
3.1.2. CDC42 modulates WASp phosphorylation by Lyn and
Btk. In contrast to RBL-2H3 cells, infection of BHK cells
with recombinant vaccinia viruses encoding Btk induced the
phosphorylation of several cellular proteins and this phos-
phorylation pattern was further increased upon expression
of Btk* (data not shown). In order to examine whether
WASp may be a substrate for Btk, BHK cells which do not
express detectable endogenous levels of WASp were transi-
ently transfected with a WASp-myc construct in combination
with Btk, Btk* or Lyn as a control. As shown in Fig. 3, anti-
phosphotyrosine immunoblotting analysis (4G10) demon-
strated that Btk (lane 5) and to a greater extent the activated
Btk* (lane 10) induced tyrosine phosphorylation of WASp-
myc, although they were less potent than Lyn (lane 8).
Rho GTPases are believed to regulate the translocation of
speci¢c e¡ectors to target membrane sites of the cell. There-
fore, we tested the possibility that overexpression of
V12CDC42, a GTPase-defective mutant form which should
bind to WASp, may modulate WASp phosphorylation by
facilitating its membrane recruitment. WASp-myc and
V12CDC42 were coexpressed in combination with the various
PTKs and WASp-myc was puri¢ed with the GSTproSH3 con-
struct. Anti-myc tag immunoblotting analysis demonstrated
that equal amounts of WASp-myc were recovered from the
di¡erent cell lysates (Kmyc blot, middle panel). In addition,
anti-CDC42 antibodies could detect V12CDC42 in the mate-
rial recovered with the GSTproSH3 beads (KCdc42 blot, low-
er panel). Recovery of V12CDC42 on the Btk GSTproSH3
beads did not occur in the absence of WASp-myc coexpres-
sion (data not shown). These ¢ndings indicate that WASp-
myc and V12CDC42 were in a complex. Interestingly, expres-
sion of V12CDC42 resulted in a 3^5-fold increase in WASp-
myc tyrosine phosphorylation by Btk, Lyn or Btk* (compare
lanes 5 and 6; 8 and 9; 10 and 11, respectively).
3.1.3. Btk and Lyn directly associate with WASp. The
above results clearly show that Lyn and Btk play a crucial
role in WASp tyrosine phosphorylation and that this event is
regulated by CDC42. The interaction of WASp to the isolated
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Fig. 1. WASp is tyrosine phosphorylated in RBL-2H3 cells. A: RBL-2H3 cell lysates were incubated with GST constructs corresponding to dif-
ferent domains of Btk bound to gluthatione-Sepharose beads: isolated Btk SH3 domain (lane 1); Pro265 to Leu substitution in the Btk SH3 do-
main (lane 2); Btk SH3 domain extended with the amino-terminal proline-rich region of Btk (lane 3); and mutated GST-ProSH3P265L (lane
4). The bound proteins were separated by SDS-PAGE, electrotransferred and immunoblotted with anti-WASp antibodies (KWASp). In lane 5,
total cell lysate corresponding to one ¢ftieth of the material used for a⁄nity puri¢cation was immunoblotted with anti-WASp. B: RBL-2H3
cells either non-stimulated (lane 1) or stimulated for 5 min by FcORI crosslinking with anti-FcORI K chain mAb (clone BC4, lane 3). RBL cells
transiently overexpressing C-terminally myc-tagged WASp unstimulated (lane 2) or after FcORI crosslinking (lane 4). Cell lysates were incubated
with Btk GST-ProSH3 gluthatione-Sepharose beads. Bound proteins were separated by SDS-PAGE and immunoblotted with anti-phosphotyro-
sine mAb (4G10). The asterisk represents a 125-kDa tyrosine phosphorylated protein further identi¢ed as Cbl (data not shown). Arrow: un-
identi¢ed 75-kDa species. The blot was stripped and successively probed with anti-WASp antibodies (KWASp) and then with anti myc-tag
mAb (Kmyc). C: Lysates of control RBL cells (RBL) or RBL cells stably transfected with WASp-myc construct (Wmyc) were stimulated with
pervanadate for 10 min. WASp-myc was immunoprecipitated with anti-myc tag mAb and immunoblotted with anti-phosphotyrosine mAb
(4G10). After stripping, the blot was reprobed with anti-WASp antibodies (KWASp). Molecular weight standards are indicated (kDa).
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SH3 domain of Lyn or Btk in vitro ([8,10] and this study)
suggests that WASp may directly associate with the PTKs in
vivo. In order to investigate this possibility, RBL-2H3 cells
expressing WASp-myc were infected with recombinant vacci-
nia viruses expressing the di¡erent PTKs Lyn, Btk or an SH3
domain deleted form of Btk (Btk-vSH3). Overexpressed Lyn
or Btk were immunoprecipitated using speci¢c antibodies and
the immunoprecipitates were analyzed for the presence of myc
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Fig. 2. Lyn-induced phosphorylation of WASp. A: RBL-2H3 cells (1.5U106) were infected with recombinant vaccinia viruses expressing the
PTKs Syk, expressed as a transmembrane CD16/7/Syk chimeric protein [28] (Syk) or native Btk or Lyn. Total cell lysates were subjected to
anti-phosphotyrosine immunoblotting analysis (4G10). B: Control for PTK expression. Upper panel: Surface expression of the CD16-contain-
ing chimera was demonstrated by FACS analysis with anti-CD16 mAb of CD16/7/Syk-infected RBL-2H3 cells (Syk) or Lyn-infected cells as a
negative control (Lyn). Lyn and Btk expression was determined by immunoblotting analysis of Btk-(lane 1) or Lyn-(lane 2) infected cell lysates
with anti-Btk (KBtk) or anti-Lyn antibodies (KLyn). C: RBL-2H3 cells expressing the CD16/7/Syk (Syk), Btk or Lyn in combination with myc-
tagged WASp (+) or without (3) were lysed and incubated with the Btk GST-proSH3 fusion protein immobilized on glutathione-Sepharose
beads. Bound proteins were separated by SDS-PAGE and after transfer were analyzed by immunoblotting with anti-phosphotyrosine mAb
(4G10). After stripping, the membrane was reprobed with anti-WASp antibodies (KWASp) to demonstrate that endogenous and myc-tagged
WASp were recovered in equal amounts from the di¡erent samples.
Fig. 3. V12CDC42 expression increases tyrosine phosphorylation of WASp by Lyn and Btk. BHK cells expressing WASp-myc alone or in com-
bination with V12CDC42 were infected with recombinant vaccinia viruses coding for wild-type Btk, Lyn or the active PH domain mutant form
Btk*. WASp-myc was recovered after binding to the Btk proSH3 construct and tyrosine phosphorylation was examined by immunoblotting
with 4G10 mAb (upper panel). The lower molecular weight species which is detected in the Lyn-infected samples corresponds to Lyn (data not
shown). Middle panel: the 4G10 blot was stripped and reprobed with anti-myc tag mAb to show relative recovery level. Lower panel: the blot
was restripped and reprobed with anti-CDC42. Anti-Lyn and anti-Btk immunoblots demonstrated that the expression levels of the PTKs in to-
tal cell lysates were equal (data not shown).
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tagged WASp. As shown in Fig. 4A, WASp-myc was present
in the anti-Lyn immunoprecipitate. Similarly, overexpressed
wild-type Btk could be co-immunoprecipitated with the
WASp-myc protein (Fig. 4B). In contrast, deletion of the
SH3 domain of Btk totally prevented the formation of this
complex. Therefore, we conclude that Lyn and Btk are both
capable of interacting with WASp in vivo, and that, as sug-
gested by in vitro analysis with isolated domains [9,10], inter-
action with Btk requires the presence of an intact SH3 do-
main.
4. Discussion
In this study, we demonstrate that WASp is tyrosine phos-
phorylated at a basal level in unstimulated RBL-2H3 cells and
that phosphorylation is further increased upon FcORI-aggre-
gation (Fig. 1). Using vaccinia-driven expression of Syk, Lyn
and Btk, which are involved in FcORI-signaling, we observe
that only Lyn and Btk could phosphorylate WASp (Figs. 2
and 3). Lyn, which belongs to the Src-family PTKs, has been
implicated in cell signaling through a number of hemato-
poietic cell speci¢c surface receptors including FcORI [16].
The current model based on much experimental data is that
Lyn is bound to FcORIL and becomes activated upon FcORI-
aggregation. Activated Lyn phosphorylates the ITAMs of the
FcORIL and Q subunits allowing SH2-mediated recruitment of
Syk and signal propagation (reviewed in [29]). Expression of
the CD16/7/Syk chimera which mimics an activated Syk at the
plasma membrane [28], was not able to trigger WASp phos-
phorylation although it induced an overall increase of tyrosine
phosphorylation in RBL-2H3 cells (Fig. 2). This result sug-
gests that Lyn-induced phosphorylation of WASp is very
likely independent of Syk activation.
A di¡erent situation was observed in the case of Btk which
also becomes activated in response to FcORI-crosslinking [19].
As in the case of Syk, Lyn is very likely instrumental for Btk
activation since Src-family PTKs have been shown to phos-
phorylate tyrosine 551 of Btk, an event that leads to Btk
activation [31]. Overexpression of Btk resulted in phosphory-
lation of WASp on tyrosine residues (Fig. 3). These results
identify WASp as the third known substrate of Btk together
with BAP-135, a protein of unknown function [32] and PLCQ
that links Btk to the regulation of intracellular Ca2 mobili-
zation [33]. Defects in the gene encoding Btk result in a severe
block in B cell development and are associated with immuno-
logical diseases in human (XLA) [20] and mouse (Xid) [21].
Interestingly, WAS, which is associated with a range of im-
mune defects culminating in a profound thrombocytopenia,
a¡ects also B cell responses such as the response to polysac-
charide antigens [1]. Therefore, the observation that Lyn and
Btk possibly act upstream of WASp adds further evidence to
the critical involvement of WASp in immune receptor signal-
ing.
An interesting ¢nding revealed by this study is that the
interaction of CDC42 with its e¡ector modulates WASp phos-
phorylation by Lyn and Btk (Fig. 3). WASp has been shown
to interact with the GTP-bound form of CDC42 through a
region, the CDC42/Rac1 interacting binding (CRIB) domain,
which is conserved in several potential target e¡ectors for
both CDC42 and Rac1 [34]. Overexpression of V12CDC42,
an activated mutant form which mimics GTP-bound CDC42,
resulted in a substantial increase of Btk- or Lyn-mediated
phosphorylation of WASp in BHK cells (Fig. 3). In mast cells
Lyn is constitutively bound to the cytoplasmic portion of
FcORIL [35] and FcORI-aggregation causes the activation of
Btk which translocates to the membrane [19]. Therefore, a
possible scenario is that GTP-bound CDC42 interacts with
and recruits WASp to the plasma membrane in the vicinity
of activated membrane-associated PTKs. Membrane associa-
tion of WASp could be further stabilized by its amino-termi-
nal PH domain. Many mutations found in WAS patients map
within this N-terminal portion of the WAS gene product [2]
indicating that the PH domain is crucial for WASp function.
This assumption is further supported by the observation that
Btk*, a PH domain mutant with increased membrane binding
[30], is more active than native Btk in phosphorylating WASp
(Fig. 3).
What might be the functional consequences of these inter-
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Fig. 4. Btk and Lyn directly associate with WASp in vivo. RBL-2H3 cells (1.5U106) overexpressing C-terminally myc-tagged WASp in combi-
nation with Lyn (L), Btk (B), or an SH3-deleted form of Btk (Bv3) were lysed and Lyn or Btk were immunoprecipitated using anti-Lyn
(KLyn, panel A) or anti-Btk (KBtk, panel B) speci¢c rabbit antibodies. Speci¢city of the antibodies was demonstrated by immunoprecipitation
using irrelevant rabbit antibodies (irr). After SDS-PAGE and electrotransfer the presence of WASp-myc (arrow) in the immunoprecipitates was
assessed by immunoblotting analysis using anti-myc tag mAb (Kmyc). The position of the rabbit IgG heavy chain that cross-reacted with the
anti-mouse IgG secondary antibodies used for the detection is indicated (IgH). The lower panels show that Lyn, Btk and SH3-deleted Btk over-
expressed proteins were e¡ectively immunoprecipitated with the corresponding antibodies. The positions of native Btk (B) and SH3-deleted
form of Btk (Bv3) are indicated.
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actions and of WASp tyrosine phosphorylation which link
Lyn, Btk, WASp and its partner CDC42 into a common
signaling pathway in mast cells? We have previously shown
that Rac1 and CDC42 control FcORI-induced actin cytoske-
leton reorganization and exocytosis of in£ammatory media-
tors in RBL-2H3 cells [12], two phenomena which require
PTK activity [14,15]. Therefore, WASp represents an attrac-
tive candidate e¡ector for mediating CDC42 function in
FcORI-dependent cytoskeletal changes. Overexpression of
WASp in Jurkat T lymphocytes induces the formation of F-
actin rich clusters that also contain WASp [4]. N-WASp, a
brain isoform, is capable of depolymerizing actin ¢laments
and this activity requires the presence of a carboxy-terminal
co¢lin-homology region which is conserved in WASp [36].
Tyrosine phosphorylation of WASp may regulate its actin
¢lament organization activity. Another, non-exclusive, possi-
bility is that tyrosine phosphorylation of WASp may modu-
late the a⁄nity of the WASp/CDC42 complex. In this respect,
it is worth noting that the consensus Lyn-phosphorylation site
which has been recently de¢ned (L/I-Y-D/E-X-L [37]), is rep-
resented once in the primary sequence of human and mouse
WAS proteins (I-Y291-D-F-I [2,38]) and is also conserved in
N-WASp [36]. Interestingly, this site is adjacent to the CRIB
domain (positions 236^253 of human WASp [2]) and the pos-
sibility exists that phosphorylation of Tyr291 may modulate,
either positively or negatively, the a⁄nity of WASp for its
target Rho GTPase. Finally, tyrosine phosphorylation of
PSTPIP, a cytoskeletal protein, has been recently shown to
regulate interaction of PSTPIP with WASp, supporting the
conclusion that tyrosine kinase activity is actually involved
in controlling WASp function in cytoskeleton organization
[39].
WAS is a pleiotropic immunode¢ciency that a¡ects platelet
architecture and function but also B and T cell responses. Our
¢ndings provide evidence for the pivotal role of WASp in
hematopoietic cell signaling by coordinating Rho GTPase
functions in cytoskeleton and cell proliferation with tyrosine
kinase signaling pathways.
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